These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31534099)

  • 1. [THE EFFECTS OF LAMA ON ASTHMA AND THE THERAPY OF BIOLOGICAL AGENTS IN SEVERE ASTHMA].
    Tagaya E
    Arerugi; 2019; 68(8):904-910. PubMed ID: 31534099
    [No Abstract]   [Full Text] [Related]  

  • 2. Muscarinic antagonists in early stage clinical development for the treatment of asthma.
    Albertson TE; Chenoweth JA; Adams JY; Sutter ME
    Expert Opin Investig Drugs; 2017 Jan; 26(1):35-49. PubMed ID: 27927039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Treatments for Asthma.
    Huang J; Pansare M
    Pediatr Clin North Am; 2019 Oct; 66(5):925-939. PubMed ID: 31466682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Acting Muscarinic Antagonists for Difficult-to-Treat Asthma: Emerging Evidence and Future Directions.
    Bulkhi A; Tabatabaian F; Casale TB
    Drugs; 2016 Jul; 76(10):999-1013. PubMed ID: 27289376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and Management of Asthma in Adults: A Review.
    McCracken JL; Veeranki SP; Ameredes BT; Calhoun WJ
    JAMA; 2017 Jul; 318(3):279-290. PubMed ID: 28719697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma biologics: Underuse, overuse, and best use?
    Rank MA; Oppenheimer JJ
    Ann Allergy Asthma Immunol; 2019 Apr; 122(4):358-359. PubMed ID: 30578858
    [No Abstract]   [Full Text] [Related]  

  • 7. Selection of Biologics in Severe Asthma: A Multifaceted Algorithm.
    Dávila I; Quirce S; Olaguibel JM
    J Investig Allergol Clin Immunol; 2019; 29(4):325-328. PubMed ID: 30969172
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug Development and Biologics in Asthma. A New Era.
    Doyle R
    Ann Am Thorac Soc; 2016 Mar; 13 Suppl 1():S83-4. PubMed ID: 27027958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma: management of severe disease.
    O'Byrne PM; Naji N
    Lancet Respir Med; 2013 Mar; 1(1):e3-4. PubMed ID: 24321815
    [No Abstract]   [Full Text] [Related]  

  • 10. Biologics, Clinical Context, and the Asthmas.
    Casale TB; Israel E
    J Allergy Clin Immunol Pract; 2019; 7(5):1437-1439. PubMed ID: 31076059
    [No Abstract]   [Full Text] [Related]  

  • 11. What is the current role of biologics in the management of patients with severe refractory asthma?
    Draikiwicz S; Oppenheimer J
    Ann Allergy Asthma Immunol; 2016 May; 116(5):383-7. PubMed ID: 27153737
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe asthma and biologics: Data are good, listening to patients is better.
    Bukstein DA; Guerra DG
    Ann Allergy Asthma Immunol; 2021 Sep; 127(3):285-286. PubMed ID: 34479728
    [No Abstract]   [Full Text] [Related]  

  • 13. Biologics in severe asthma: Which one, When and Where?
    Rupani H; Murphy A; Bluer K; Renwick C; McQuitty P; Jackson DJ; Heaney LG; Chaudhuri R; Menzies-Gow A; Calvert J; Siddiqui S
    Clin Exp Allergy; 2021 Sep; 51(9):1225-1228. PubMed ID: 34289191
    [No Abstract]   [Full Text] [Related]  

  • 14. Biologics in Asthma: Emerging Biologics.
    Desai B; Adrish M; Mohan A; Lugogo NL
    Immunol Allergy Clin North Am; 2024 Nov; 44(4):751-763. PubMed ID: 39389722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic Targeting: New and Effective Therapeutic Approaches against Severe Asthma.
    Yang X; Feng HR; Chen ZM; Ying SM
    Chin Med J (Engl); 2018 May; 131(9):1009-1012. PubMed ID: 29692369
    [No Abstract]   [Full Text] [Related]  

  • 16. Asthma treatments: new and emerging therapies.
    Calhoun KH
    Int Forum Allergy Rhinol; 2015 Sep; 5 Suppl 1():S76-81. PubMed ID: 26335840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [INTRODUCTION AND SELECTION OF BIOLOGICS FOR PEDIATRIC ASTHMA].
    Tezuka J
    Arerugi; 2021; 70(5):359-365. PubMed ID: 34275991
    [No Abstract]   [Full Text] [Related]  

  • 18. How to compare the efficacy of biologic agents in asthma.
    Viswanathan RK; Busse WW
    Ann Allergy Asthma Immunol; 2020 Aug; 125(2):137-149. PubMed ID: 32387169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis.
    Sobieraj DM; Baker WL; Nguyen E; Weeda ER; Coleman CI; White CM; Lazarus SC; Blake KV; Lang JE
    JAMA; 2018 Apr; 319(14):1473-1484. PubMed ID: 29554174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guiding principles for use of newer biologics and bronchial thermoplasty for patients with severe asthma.
    Blaiss MS; Castro M; Chipps BE; Zitt M; Panettieri RA; Foggs MB
    Ann Allergy Asthma Immunol; 2017 Dec; 119(6):533-540. PubMed ID: 29103801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.